Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study

por Marzo‐Ortega, H., Sieper, J., Kivitz, A., Blanco, R., Cohen, M., Martin, R., Readie, A., Richards, H. B., Porter, B.
Publicado 2017

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

por Braun, J., Haibel, H., de Hooge, M., Landewé, R., Rudwaleit, M., Fox, T., Readie, A., Richards, H. B., Porter, B., Martin, R., Poddubnyy, D., Sieper, J., van der Heijde, D.
Publicado 2019